theranostics

Aurora Oncology is a pre-clinical biotechnology start-up created by scientists and physicians at the University of Colorado Anschutz Medical Campus and Boulder Campus. It is dedicated to developing drugs and diagnostics to treat bladder cancer, bringing discoveries from the research bench to patients with targetable tumors. The company is a member of the SPARK program and has received funding from NIH, the State of Colorado, and CU Innovations.

Read more

diagnostics developmentdrug developmenttargeted therapythermal ablation

Cellular Nanomed Inc. develops patented magnetoelectric nano-therapy technology using biocompatible magnetoelectric nanoparticles (MENPs) that, when activated by a magnetic field, generate electric fields on cancer cells to cause cell death. The technology has been tested in animal experiments, including a preclinical study at NCI Moffitt Cancer Center showing complete remission of pancreatic cancer from a single treatment. The company also works on applications including intracellular drug delivery, neuromodulation, and brain-computer interface.

Read more

brain-computer interfacemagnetoelectric nano-therapynanoparticle-based cancer treatmentNeuromodulation